1-(bromomethyl)-4-(methoxymethyl)benzene | 95349-71-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(bromomethyl)-4-(methoxymethyl)benzene
• 英文别名: 1-bromomethyl-4-methoxymethylbenzene
• CAS: 95349-71-6
• 化学式: C₉H₁₁BrO
• 分子量: 215.09
• InChiKey: CPGGWEMHYNBPPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(bromomethyl)-4-(methoxymethyl)benzene 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 18.0h， 生成 2-(4-(triisopropylsiloxymethyl)phenyl)-5-(4-(methoxymethyl)phenyl)-3,4-bis-(4-bromophenyl)cyclopenta-2,4-dienone
  参考文献：
  名称：

  Synthesis of Heterosubstituted Hexaarylbenzenes via Asymmetric Carbonylative Couplings of Benzyl Halides

  摘要：

  Asymmetric carbonylative couplings of benzyl halides have been shown to give heterosubstituted 1,3-diarylacetones in moderate to high yields. These asymmetric ketones were converted via Knoevenagel condensations to tetraarylcyclopentadienones, and further conversion via dehydro-Diels-Alder cycloadditions gave highly heterofunctionalized hexaarylbenzenes with uniquely functionalized aryl groups at the para positions of the central benzene. This method allows control of the substituents on each of four unique pendent aryl group positions, giving rise to substitution patterns not available using symmetrical 1,3-diarylacetones.

  DOI：

  10.1021/ol0629770
• 作为产物：
  描述：

  对苯二甲醇 在 N-溴代丁二酰亚胺(NBS) 、 二甲基硫 、 sodium hydride 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 0.5h， 生成 1-(bromomethyl)-4-(methoxymethyl)benzene
  参考文献：
  名称：

  Synthesis of Heterosubstituted Hexaarylbenzenes via Asymmetric Carbonylative Couplings of Benzyl Halides

  摘要：

  Asymmetric carbonylative couplings of benzyl halides have been shown to give heterosubstituted 1,3-diarylacetones in moderate to high yields. These asymmetric ketones were converted via Knoevenagel condensations to tetraarylcyclopentadienones, and further conversion via dehydro-Diels-Alder cycloadditions gave highly heterofunctionalized hexaarylbenzenes with uniquely functionalized aryl groups at the para positions of the central benzene. This method allows control of the substituents on each of four unique pendent aryl group positions, giving rise to substitution patterns not available using symmetrical 1,3-diarylacetones.

  DOI：

  10.1021/ol0629770

文献信息

• Novel Spiropiperidine Compounds
  申请人：Hamdouchi Chafiq

  公开号：US20110092531A1

  公开（公告）日：2011-04-21

  A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.

  一个化学式为的化合物： 或其药用可接受的盐，以及一种治疗糖尿病的药物组合物和方法。
• [EN] HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE PAD
  申请人：JUBILANT BIOSYS LTD

  公开号：WO2019058393A1

  公开（公告）日：2019-03-28

  Heterocyclic compounds of Formula (I), (II), and (III) are described herein along with their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites thereof. The compounds described herein, their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites thereof are PAD4 inhibitors and may be useful in the treatment of various disorders, for example rheumatoid arthritis, vasculitis, systemic lupus erythematosis, cutaneous lupus erythematosis, ulcerative colitis, cancer, cystic fibrosis, asthma, multiple sclerosis and psoriasis.

  公式（I）、（II）和（III）的杂环化合物以及它们的多晶形态、立体异构体、前药、溶剂合物、共晶体、中间体、药学上可接受的盐和代谢物在此处描述。本文描述的化合物及其多晶形态、立体异构体、前药、溶剂合物、共晶体、中间体、药学上可接受的盐和代谢物是PAD4抑制剂，可能在治疗各种疾病中有用，例如类风湿关节炎、血管炎、系统性红斑狼疮、皮肤红斑狼疮、溃疡性结肠炎、癌症、囊性纤维化、哮喘、多发性硬化和牛皮癣。
• CYCLIC AMIDE DERIVATIVE
  申请人：Okano Akihiro

  公开号：US20130203739A1

  公开（公告）日：2013-08-08

  [Problem] To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogues and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of solving the problem] A compound of Formula (1): (where n is 0 to 2; p is 0 to 4; h is 0 to 3; j is 0 to 3; k is 0 to 2; a ring B is an aryl group or a heteroaryl group; X is O, S, or —NR 7 —; J 1 is —CR 11a R 11b — or —NR 11c —; J 2 is —CR 12a R 12b — or —NR 12c —; and R 1 to R 12c are specific groups), a salt of the compound, or a solvate of the salt or the compound.

  为提供一种具有GPR40激活剂作用的新化合物、该化合物的盐、盐或化合物的溶剂合物，尤其是胰岛素分泌剂和预防和/或治疗糖尿病、肥胖或其他疾病的药剂，解决问题的方法是使用Formula (1)的化合物：(其中n为0至2；p为0至4；h为0至3；j为0至3；k为0至2；环B为芳香族或杂环芳基；X为O、S或-NR7-；J1为-CR11aR11b-或-NR11c-；J2为-CR12aR12b-或-NR12c-；R1到R12为特定基团)，该化合物的盐，或盐或化合物的溶剂合物。
• NOVEL 3-HYDROXYISOTHIAZOLE 1-OXIDE DERIVATIVE
  申请人：OHKOUCHI Munetaka

  公开号：US20120277150A1

  公开（公告）日：2012-11-01

  [Object] To provide a GPR40 activating agent containing, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the compound or the salt, or the like, particularly, an insulin secretagogue and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of Solving the Problem] A compound of Formula (I): (where p is 0 to 4; j is 0 to 2; k is 0 to 1; a ring A is an aryl group, a heterocyclic group, a cycroalkyl group, a cycroalkenyl group, a spirocyclic group; a ring B is an aryl group, a heteroaryl group; X is 0 or —NR 7 —; and R 1 to R 7 and L are specific groups), a salt of the compound, or a solvate of the compound or the salt.

  提供一种包含GPR40激活剂的药剂，其活性成分为具有GPR40激动剂作用的新化合物、该化合物的盐、该化合物或盐的溶剂化合物等，特别是胰岛素促分泌剂和预防和/或治疗糖尿病、肥胖或其他疾病的药物。解决问题的方法是使用式(I)的化合物：（其中p为0至4；j为0至2；k为0至1；环A为芳基、杂环基、环烷基、环烯基、螺环基；环B为芳基、杂芳基；X为0或-NR7-；R1至R7和L为特定基团），该化合物的盐或该化合物或盐的溶剂化合物。
• Derivative of ester of carboxylic acid, and insecticide and insect
  申请人：Dainihon Jochugiku Co., Ltd.

  公开号：US06107339A1

  公开（公告）日：2000-08-22

  The derivatives of esters of carboxylic acids represented by the general formula I: ##STR1## wherein: R.sub.1 is an alkyl group having a chain or branched chain of 1 to 4 carbon atoms; and R.sub.2 is a group represented by the following general formulae II, III or IV; ##STR2## wherein: R.sub.3 is a hydrogen atom or a methyl group; X is an oxygen atom or a methylidene group; R.sub.4 is an hydrogen atom or an ethynyl group; R.sub.5 and R.sub.6 are alike or differently selected from the group consisting of hydrogen, fluorine, chlorine atoms or methyl group; R.sub.7 is a hydrogen atom or a trifluoromethyl group; R.sub.8 is selected from the group consisting of propargyl, methoxymethyl or methylthio groups; or R.sub.7 and R.sub.8 may combine with each other to form a methylenedioxy chain; and the process for manufacturing the same, and the insecticides and the insect proofing agents containing the same as an active ingredient. The compounds represented by the general formula I are useful ingredients of insecticides and insect proofing agents which have both a fast-acting property and a lethal effect, and moreover, are highly safe to mammals; and therefore, insecticides and insect proofing agents containing the above compounds have a highly practical use.

  一般式I所代表的羧酸酯衍生物的导数：##STR1## 其中：R.sub.1是链状或支链状的1至4个碳原子的烷基基团；R.sub.2是由以下一般式II，III或IV所代表的基团；##STR2## 其中：R.sub.3是氢原子或甲基基团；X是氧原子或甲基亚砜基团；R.sub.4是氢原子或乙炔基团；R.sub.5和R.sub.6相同或不同，选自氢、氟、氯原子或甲基基团的群；R.sub.7是氢原子或三氟甲基基团；R.sub.8选自丙炔基、甲氧基甲基或甲硫基基团；或R.sub.7和R.sub.8可以结合形成亚甲二氧基链；以及其制造过程，以及含有其作为活性成分的杀虫剂和防虫剂。一般式I所代表的化合物是杀虫剂和防虫剂的有用成分，具有快速作用和致死效果，并且对哺乳动物非常安全；因此，含有上述化合物的杀虫剂和防虫剂具有高度实用价值。